{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:46:48Z","timestamp":1792673208842,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1038\/s41433-021-01505-1","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T09:05:03Z","timestamp":1617267903000},"page":"612-618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anti-TB monotherapy for choroidal tuberculoma: an observational study"],"prefix":"10.1038","volume":"36","author":[{"given":"Ashish","family":"Khalsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3983-4200","authenticated-orcid":false,"given":"Anup","family":"Kelgaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6513-8786","authenticated-orcid":false,"given":"Soumyava","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"1505_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/bjophthalmol-2016-309531.","volume":"101","author":"M Ang","year":"2017","unstructured":"Ang M, Chee SP. Controversies in ocular tuberculosis. Br J Ophthalmol. 2017;101:6\u20139. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309531.","journal-title":"Br J Ophthalmol"},{"key":"1505_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00006982-200302000-00018.","volume":"23","author":"PM Sharma","year":"2003","unstructured":"Sharma PM, Singh RP, Kumar A, Prakash G, Mathur MB, Malik P. Choroidal tuberculoma in miliary tuberculosis. Retina. 2003;23:101\u20134. https:\/\/doi.org\/10.1097\/00006982-200302000-00018.","journal-title":"Retina"},{"key":"1505_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1473-3099(15)00269-8.","volume":"16","author":"D Heiden","year":"2016","unstructured":"Heiden D, Saranchuk P, Keenan JD, Ford N, Lowinger A, Yen M, et al. Eye examination for early diagnosis of disseminated tuberculosis in patients with AIDS. Lancet Infect Dis. 2016;16:493\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(15)00269-8.","journal-title":"Lancet Infect Dis"},{"key":"1505_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0161-6420(85)33964-7","volume":"92","author":"CE Lyon","year":"1985","unstructured":"Lyon CE, Grimson BS, Peiffer RL Jr, Merritt JC. Clinicopathological correlation of a solitary choroidal tuberculoma. Ophthalmology. 1985;92:845\u201350.","journal-title":"Ophthalmology."},{"key":"1505_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/s0002-9394(14)76260-9.","volume":"112","author":"MJ Barondes","year":"1991","unstructured":"Barondes MJ, Sponsel WE, Stevens TS, Plotnik RD. Tuberculous choroiditis diagnosed by chorioretinal endobiopsy. Am J Ophthalmol. 1991;112:460\u20131. https:\/\/doi.org\/10.1016\/s0002-9394(14)76260-9.","journal-title":"Am J Ophthalmol"},{"key":"1505_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ophtha.2010.08.011.","volume":"118","author":"KJ Wroblewski","year":"2011","unstructured":"Wroblewski KJ, Hidayat AA, Neafie RC, Rao NA, Zapor M. Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology. 2011;118:772\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2010.08.011.","journal-title":"Ophthalmology."},{"key":"1505_CR7","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/archophthalmol.2009.220","volume":"127","author":"NA Rao","year":"2009","unstructured":"Rao NA, Albini TA, Kumaradas M, Pinn ML, Fraig MM, Karakousis PC. Experimental ocular tuberculosis in guinea pigs. Arch Ophthalmol. 2009;127:1162\u20136.","journal-title":"Arch Ophthalmol"},{"key":"1505_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/09273948.2016.1178304","volume":"26","author":"M Ang","year":"2018","unstructured":"Ang M, Vasconcelos-Santos DV, Sharma K, Accorinti M, Sharma A, Gupta A, et al. Diagnosis of ocular tuberculosis. Ocul Immunol Inflamm. 2018;26:208\u201316.","journal-title":"Ocul Immunol Inflamm"},{"key":"1505_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41433-019-0543-7","volume":"34","author":"H Petrushkin","year":"2020","unstructured":"Petrushkin H, Sethi C, Potter J, Martin L, Russell G, White V, et al. Developing a pathway for the diagnosis and management of ocular tuberculosis. The pan-LOndon ocular tuberculosis pathway-LOOP. Eye. 2020;34:805\u20138.","journal-title":"Eye."},{"key":"1505_CR10","doi-asserted-by":"publisher","unstructured":"Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM et al. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis\u2014Report 1. Ophthalmology. 2020;S0161-6420 30013-0. (published ahead of print). https:\/\/doi.org\/10.1016\/j.ophtha.2020.01.008.","DOI":"10.1016\/j.ophtha.2020.01.008"},{"key":"1505_CR11","doi-asserted-by":"publisher","unstructured":"Nahon-Esteve S, Martel A, Maschi C, Alketbi M, Baillif S, Tieulie N Uveitis associated with latent tuberculosis: a comparative study of the impact of antitubercular therapy combined or not with systemic corticosteroids. Eur J Ophthalmol. 2020:1120672120962066. https:\/\/doi.org\/10.1177\/1120672120962066. Epub ahead of print.","DOI":"10.1177\/1120672120962066"},{"key":"1505_CR12","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/IAE.0b013e3182215b5e.","volume":"32","author":"M Zhang","year":"2012","unstructured":"Zhang M, Zhang J, Liu Y. Clinical presentations and therapeutic effect of presumed choroidal tuberculosis. Retina. 2012;32:805\u201313. https:\/\/doi.org\/10.1097\/IAE.0b013e3182215b5e.","journal-title":"Retina"},{"key":"1505_CR13","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1167\/iovs.18-24102.","volume":"59","author":"R Agrawal","year":"2018","unstructured":"Agrawal R, Gunasekeran DV, Raje D, Agarwal A, Nguyen QD, Kon OM, et al. Global variations and challenges with tubercular uveitis in the collaborative ocular tuberculosis study. Invest Ophthalmol Vis Sci. 2018;59:4162\u201371. https:\/\/doi.org\/10.1167\/iovs.18-24102.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1505_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.survophthal.2016.03.001.","volume":"61","author":"AR Kee","year":"2016","unstructured":"Kee AR, Gonzalez-Lopez JJ, Al-Hity A, Gupta B, Lee CS, Gunasekeran DV, et al. Anti-tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis. Surv Ophthalmol 2016;61:628\u201353. https:\/\/doi.org\/10.1016\/j.survophthal.2016.03.001.","journal-title":"Surv Ophthalmol"},{"key":"1505_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1086\/515543.","volume":"25","author":"DP Dooley","year":"1997","unstructured":"Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis. 1997;25:872\u201387. https:\/\/doi.org\/10.1086\/515543.","journal-title":"Clin Infect Dis."},{"key":"1505_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S1473-3099(13)70009-4.","volume":"13","author":"GE Thwaites","year":"2013","unstructured":"Thwaites GE. Adjunctive corticosteroids for all forms of tuberculosis? Lancet Infect Dis. 2013;13:186\u20138. https:\/\/doi.org\/10.1016\/S1473-3099(13)70009-4.","journal-title":"Lancet Infect Dis."},{"key":"1505_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ajo.2018.02.019","volume":"189","author":"JV Forrester","year":"2018","unstructured":"Forrester JV, Kuffova L, Dick AD. Autoimmunity, autoinflammation, and infection in uveitis. Am J Ophthalmol. 2018;189:77\u201385.","journal-title":"Am J Ophthalmol"},{"key":"1505_CR18","doi-asserted-by":"publisher","first-page":"101961","DOI":"10.1016\/j.tube.2020.101961","volume":"124","author":"S Basu","year":"2020","unstructured":"Basu S, Elkington P, Rao N. Pathogenesis of ocular tuberculosis\u2014new observations and future observations. Tuberculosis. 2020;124:101961.","journal-title":"Tuberculosis."},{"key":"1505_CR19","first-page":"565","volume":"18","author":"M Ang","year":"2012","unstructured":"Ang M, Cheung G, Vania M, Chen J, Yang H, Li J, et al. Aqueous cytokine and chemokine analysis in uveitis associated with tuberculosis. Mol Vis. 2012;18:565\u201373.","journal-title":"Mol Vis"},{"key":"1505_CR20","doi-asserted-by":"publisher","first-page":"5682","DOI":"10.1167\/iovs.17-22462.","volume":"58","author":"R Tagirasa","year":"2017","unstructured":"Tagirasa R, Parmar S, Barik MR, Devadas S, Basu S. Autoreactive T cells in immunopathogenesis of TB-associated uveitis. Invest Ophthalmol Vis Sci 2017;58:5682\u201391. https:\/\/doi.org\/10.1167\/iovs.17-22462.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1505_CR21","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/bjophthalmol-2012-302199","volume":"97","author":"M Ang","year":"2013","unstructured":"Ang M, Wong WL, Li X, Chee SP. Interferon \u03b3 release assay for the diagnosis of uveitis associated with tuberculosis: a Bayesian evaluation in the absence of a gold standard. Br J Ophthalmol. 2013;97:1062\u20137.","journal-title":"Br J Ophthalmol"},{"key":"1505_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ophtha.2017.08.007.","volume":"125","author":"DA Jabs","year":"2018","unstructured":"Jabs DA. Immunosuppression for the uveitides. Ophthalmology. 2018;125:193\u2013202. https:\/\/doi.org\/10.1016\/j.ophtha.2017.08.007.","journal-title":"Ophthalmology."},{"key":"1505_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ajo.2006.01.071.","volume":"142","author":"A Salman","year":"2006","unstructured":"Salman A, Parmar P, Rajamohan M, Vanila CG, Thomas PA, Jesudasan CA. Optical coherence tomography in choroidal tuberculosis. Am J Ophthalmol. 2006;142:170\u20132. https:\/\/doi.org\/10.1016\/j.ajo.2006.01.071.","journal-title":"Am J Ophthalmol"},{"key":"1505_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0140-6736(55)90003-9.","volume":"268","author":"M Ashby","year":"1955","unstructured":"Ashby M, Grant H. Tuberculous meningitis treated with cortisone. Lancet. 1955;268:65\u20136. https:\/\/doi.org\/10.1016\/s0140-6736(55)90003-9.","journal-title":"Lancet."},{"key":"1505_CR25","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1056\/NEJMoa040573.","volume":"351","author":"GE Thwaites","year":"2004","unstructured":"Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351:1741\u201351. https:\/\/doi.org\/10.1056\/NEJMoa040573.","journal-title":"N Engl J Med"},{"key":"1505_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/heart.84.2.183.","volume":"84","author":"JG Hakim","year":"2000","unstructured":"Hakim JG, Ternouth I, Mushangi E, Siziya S, Robertson V, Malin A. Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart. 2000;84:183\u20138. https:\/\/doi.org\/10.1136\/heart.84.2.183.","journal-title":"Heart."},{"key":"1505_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4049\/jimmunol.175.1.579.","volume":"175","author":"CP Simmons","year":"2005","unstructured":"Simmons CP, Thwaites GE, Quyen NT, Chau TT, Mai PP, Dung NT, et al. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses. J Immunol 2005;175:579\u201390. https:\/\/doi.org\/10.4049\/jimmunol.175.1.579.","journal-title":"J Immunol"},{"key":"1505_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S1474-4422(07)70034-0.","volume":"6","author":"GE Thwaites","year":"2007","unstructured":"Thwaites GE, Macmullen-Price J, Tran TH, Pham PM, Nguyen TD, Simmons CP, et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol. 2007;6:230\u20136. https:\/\/doi.org\/10.1016\/S1474-4422(07)70034-0.","journal-title":"Lancet Neurol."},{"key":"1505_CR29","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.cell.2010.02.013.","volume":"140","author":"DM Tobin","year":"2010","unstructured":"Tobin DM, Vary JC Jr, Ray JP, Walsh GS, Dunstan SJ, Bang ND, et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell. 2010;140:717\u201330. https:\/\/doi.org\/10.1016\/j.cell.2010.02.013.","journal-title":"Cell."},{"key":"1505_CR30","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/infdis\/jix050.","volume":"215","author":"NTT Thuong","year":"2017","unstructured":"Thuong NTT, Heemskerk D, Tram TTB, Thao LTP, Ramakrishnan L, Ha VTN, et al. Leukotriene A4 hydrolase genotype and HIV infection influence intracerebral inflammation and survival from tuberculous meningitis. J Infect Dis. 2017;215:1020\u20138. https:\/\/doi.org\/10.1093\/infdis\/jix050.","journal-title":"J Infect Dis"},{"key":"1505_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bjophthalmol-2011-300209.","volume":"96","author":"M Ang","year":"2012","unstructured":"Ang M, Hedayatfar A, Wong W, Chee SP. Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study. Br J Ophthalmol. 2012;96:332\u20136. https:\/\/doi.org\/10.1136\/bjophthalmol-2011-300209.","journal-title":"Br J Ophthalmol"},{"key":"1505_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/eye.2009.83.","volume":"24","author":"K Babu","year":"2010","unstructured":"Babu K, Murthy PR, Murthy KR. Intravitreal bevacizumab as an adjunct in a patient with presumed vascularised choroidal tubercular granuloma. Eye. 2010;24:397\u20139. https:\/\/doi.org\/10.1038\/eye.2009.83.","journal-title":"Eye."},{"key":"1505_CR33","doi-asserted-by":"publisher","first-page":"bcr2013200255","DOI":"10.1136\/bcr-2013-200255.","volume":"2013","author":"R Bansal","year":"2013","unstructured":"Bansal R, Beke N, Sharma A, Gupta A. Intravitreal bevacizumab as an adjunct in the management of a vascular choroidal granuloma. BMJ Case Rep. 2013;2013:bcr2013200255. https:\/\/doi.org\/10.1136\/bcr-2013-200255.","journal-title":"BMJ Case Rep."},{"key":"1505_CR34","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/2281188a0.","volume":"228","author":"E P\u0103unescu","year":"1970","unstructured":"P\u0103unescu E. In vivo and in vitro suppression of humoral and cellular immunological response by rifampicin. Nature. 1970;228:1188\u201390. https:\/\/doi.org\/10.1038\/2281188a0.","journal-title":"Nature."},{"key":"1505_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4103\/0019-5154.190105.","volume":"61","author":"S Pradhan","year":"2016","unstructured":"Pradhan S, Madke B, Kabra P, Singh AL. Anti-inflammatory and immunomodulatory effects of antibiotics and their use in dermatology. Indian J Dermatol. 2016;61:469\u201381. https:\/\/doi.org\/10.4103\/0019-5154.190105.","journal-title":"Indian J Dermatol."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01505-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01505-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01505-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T09:05:23Z","timestamp":1645693523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01505-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01505-1","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"6 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}